Related Experiment Videos
Evaluation of a structured educational programme for type 2 diabetes patients seen in private practice
C Boegner1, A Fontbonne, M-F Gras Vidal
1Department of Metabolic Diseases, Lapeyronie Hospital, 371, avenue Doyen G.-Giraud, 34295 Montpellier cedex 5, France. c-boegner@chu-montpellier.fr
Diabetes & Metabolism
|April 9, 2008
Summary
Structured group education for type 2 diabetes patients in private practices improved blood glucose control and self-management skills. This feasible program demonstrated advantages for patients managing their chronic condition.
Area of Science:
- Endocrinology
- Public Health
- Medical Education
Background:
- Structured education is crucial for managing chronic diseases like type 2 diabetes.
- Patient education should be accessible across various healthcare settings.
- Group education offers a scalable approach to diabetes management.
Purpose of the Study:
- To assess the feasibility of implementing a group education program for type 2 diabetes patients in a private French practice.
- To evaluate the advantages and patient outcomes of this structured educational intervention.
- To demonstrate the benefits of multidisciplinary healthcare provider involvement.
Main Methods:
- A multidisciplinary team of volunteer healthcare providers (GPs, diabetologists, non-medical staff) delivered the education.
- Volunteers received standardized training.
- 427 type 2 diabetes patients completed baseline and 6-month follow-up questionnaires on knowledge, beliefs, and behaviors, alongside medical data collection.
Main Results:
- Patients showed consistent improvements in fasting glucose and HbA1c levels at six months.
- Key diabetes self-management parameters improved, with a significant increase in weekly foot inspection rates (67% to 77%).
- Patients demonstrated enhanced knowledge and a more positive attitude towards diabetes management.
Conclusions:
- Group educational sessions for type 2 diabetes patients are feasible within private practice settings.
- The program yielded significant benefits in glycemic control and self-management markers.
- This model provides a valuable framework for diabetes patient education in community-based healthcare.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...